A Physical Activity and Diet Just-in-Time Adaptive Intervention to Reduce Blood Pressure: The myBPmyLife Study Rationale and Design.
Journal Information
Full Title: J Am Heart Assoc
Abbreviation: J Am Heart Assoc
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosures Dr Golbus receives funding from the National Institutes of Health (NIH) (L30HL143700, 1K23HL168220‐01). Dr Dorsch receives funding from the Agency for Health Research and Quality, the National Institute of Aging, the National Heart, Lung, and Blood Institute, and the American Health Association. Dr Skolarus receives funding from the National Institute of Aging, the National Institute of Minority Health and Health Disparities, and the American Health Association. Dr Nallamothu receives funding from the NIH, VA Health Services Research & Development, American Heart Association, and Janssen. He also receives compensation as Editor‐in‐Chief of Circulation: Cardiovascular Quality & Outcomes, a journal of the American Heart Association. Finally, he is a coinventor on US utility patent number US15/356012 (US20170148158A1) entitled “Automated Analysis of Vasculature in Coronary Angiograms,” which uses software technology with signal processing and machine learning to automate the reading of coronary angiograms, held by the University of Michigan. The patent is licensed to AngioInsight, Inc, in which Dr Nallamothu holds ownership shares and receives consultancy fees. The remaining authors have no disclosures to report."
"Sources of Funding The study received a grant from the American Heart Association (AWD014891)."
"Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05154929."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025